FindMyKOL
Clinical trialNCT00004026TerminatedPhase 2Interventional

CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Therapy

SponsorCTI BioPharmaEnrollment80Prostate Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. CT-2584 may stop the growth of prostate cancer by stopping blood flow to the tumor. PURPOSE: Randomized phase II trial to study the effectiveness of CT-2584 in treating patients who have metastatic prostate cancer that has not responded to previous therapy.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Jonsson Comprehensive Cancer Center, Ucla

    Los Angeles, California, United States

  • Ucsf Cancer Center and Cancer Research Institute

    San Francisco, California, United States

  • Stanley Scott Cancer Center

    New Orleans, Louisiana, United States

  • Johns Hopkins Oncology Center

    Baltimore, Maryland, United States

  • Herbert Irving Comprehensive Cancer Center

    New York, New York, United States

  • Our Lady of Mercy Medical Center

    The Bronx, New York, United States

  • University of Washington Medical Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 1998
Primary completion
31 Jan 2005
Completion
31 Jan 2005
Last update posted
19 Oct 2020
Registered enrollment
80
Registry id
NCT00004026

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.